Related Experiment Videos
Differential expression in an antisense MYCN neuroblastoma model
M L Schmidt1, A Lal, D Dittmann
1Department of Pediatrics, University of Illinois at Chicago, Chicago, Illinois, USA. mls3@uic.edu
Medical and Pediatric Oncology
|December 7, 2000
Summary
Researchers identified novel genes affected by MYCN down-regulation in neuroblastoma (NB) using a MYCN-expressing model. Five MYCN-dependent differential expression (NDDE) genes were confirmed, offering insights into NB pathogenesis.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Utilized a previously established antisense MYCN-expressing model system.
- Investigated gene expression alterations due to MYCN down-regulation.
Purpose of the Study:
- To identify genes whose expression is modulated by MYCN.
- To discover novel MYCN-dependent differential expression (NDDE) genes in neuroblastoma.
Main Methods:
- Employed differential display to compare gene expression profiles.
- Utilized Northern blot analysis for differential expression confirmation.
- Performed GenBank searches for cDNA homology identification.
Main Results:
- Identified nine differentially expressed cDNAs (NDDE:1-9) in MYCN-downregulated cells.
- Confirmed differential expression for five NDDE cDNAs.
- NDDE:8 showed homology to PRG3, and NDDE:2 to a heat shock protein.
Conclusions:
- Discovered novel genes regulated by MYCN in neuroblastoma.
- Suggests potential roles for identified NDDE genes in NB development.
- Further analysis of these cDNAs may elucidate MYCN targets in NB.